[Exagamglogene autotemcel (transfusion-dependent β-thalassaemia) - Assessment according to §35a Social Code Book V]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005120
German
Original Title:
Exagamglogen Autotemcel (transfusionsabhängige β-Thalassämie)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g23-07.html
Year Published:
2023
URL for published report:
https://www.iqwig.de/download/g23-07_exagamglogen-autotemcel_einschaetzung-der-patientenzahlen_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- beta-Thalassemia
- Biological Products
- Genetic Therapy
- Gene Editing
- Product Surveillance, Postmarketing
- CRISPR-Cas Systems
Keywords
- Exagamglogene
- Beta-Thalassemia
- Adolescent
- Adult
- Epidemiology
- Insurance – Health
- Product Surveillance – Postmarketing
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.